Acetylsalicylic acid Recruiting Phase 4 Trials for Peripheral Arterial Disease (PAD) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02959606SAFE (Sarpogrelate Anplone in Femoro-popliteal Artery Intervention Efficacy) Study